{"id":"W2609543937","doi":"10.1093/eurheartj/ehx144","title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","year":2017,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":3840,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Servier; InfraRedx; Mylan; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Amarin Corporation; Bayer Vital; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; CSL Behring; Anthera; Danone; Alnylam Pharmaceuticals; Kowa Company; Sanofi; Amgen; Pfizer; Esperion Therapeutics; GlaxoSmithKline","keywords":"Medicine; Consensus conference; Atherosclerotic cardiovascular disease; Statement (logic); Disease; Internal medicine; Cardiology; Law","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}